CyberGene AB

CEO: Heléne Olssoncybergene


About CyberGene AB
CyberGene AB is a private Swedish company. CyberGene develop and sell diagnostic kits based upon molecular biology methods. ChromoQuant® kits diagnose chromosomal disorders. Our market is global and 90% of the sales is outside Sweden. The customers are found in clinical genetic laboratories. CyberGene has been ISO certified since 2005.

About ChromoQuant®
The first ChromoQuant® kits for prenatal diagnostics was launched in 2005. ChromoQuant® STaR diagnoses the most common chromosomal disorders in foetuses, i.e. aneuploidies in chromosomes 13, 18, 21 and X/Y. Launched in 2012. ChromoQuant® PLUS diagnoses aneuploidies in chromosomes 15, 16 and 22 and is used mainly to analyse miscarriages. Launched in 2013. ChromoQuant®AZF diagnoses male infertility due to micro deletions in the Y chromosome. Launched in 2014.


Share Button